Archive: 11/29/2010

FDA reviews 2 new drugs to reduce prostate cancer

(AP) -- Health regulators said Monday that two drugs from GlaxoSmithKline and Merck reduce the risk of prostate cancer in men, though scientists questioned the drugs' overall benefit, since the tumors they prevent are usually ...

dateNov 29, 2010 in Medications
shares0 comments 0